BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28744400)

  • 1. Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat.
    Gao MQ; Gao H; Han M; Liu KL; Peng JJ; Han YT
    Am J Cancer Res; 2017; 7(7):1501-1514. PubMed ID: 28744400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation.
    Gao H; Gao MQ; Peng JJ; Han M; Liu KL; Han YT
    Acta Pharmacol Sin; 2017 Dec; 38(12):1618-1631. PubMed ID: 29119970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
    Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
    Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPHK1 Is a Novel Target of Metformin in Ovarian Cancer.
    Hart PC; Chiyoda T; Liu X; Weigert M; Curtis M; Chiang CY; Loth R; Lastra R; McGregor SM; Locasale JW; Lengyel E; Romero IL
    Mol Cancer Res; 2019 Apr; 17(4):870-881. PubMed ID: 30655321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat [Retraction].
    Am J Cancer Res; 2020; 10(6):1921. PubMed ID: 32642301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
    Wang S; Liang Y; Chang W; Hu B; Zhang Y
    Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ.
    Han M; Gao H; Ju P; Gao MQ; Yuan YP; Chen XH; Liu KL; Han YT; Han ZW
    Biomed Pharmacother; 2018 Jul; 103():272-283. PubMed ID: 29656183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocation and activation of sphingosine kinase 1 by ceramide-1-phosphate.
    Nishino S; Yamashita H; Tamori M; Mashimo M; Yamagata K; Nakamura H; Murayama T
    J Cell Biochem; 2019 Apr; 120(4):5396-5408. PubMed ID: 30444039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPHK1 promotes metastasis of thyroid carcinoma through activation of the S1P/S1PR3/Notch signaling pathway.
    Zhao Z; Ma J; Hu B; Zhang Y; Wang S
    Exp Ther Med; 2018 Jun; 15(6):5007-5016. PubMed ID: 29805524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models.
    Rosa R; Marciano R; Malapelle U; Formisano L; Nappi L; D'Amato C; D'Amato V; Damiano V; Marfè G; Del Vecchio S; Zannetti A; Greco A; De Stefano A; Carlomagno C; Veneziani BM; Troncone G; De Placido S; Bianco R
    Clin Cancer Res; 2013 Jan; 19(1):138-47. PubMed ID: 23166225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma.
    Bao M; Chen Z; Xu Y; Zhao Y; Zha R; Huang S; Liu L; Chen T; Li J; Tu H; He X
    Liver Int; 2012 Feb; 32(2):331-8. PubMed ID: 22098666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-β-sphingosine kinase 1/S1P signaling upregulates microRNA-21 to promote fibrosis in renal tubular epithelial cells.
    Liu X; Hong Q; Wang Z; Yu Y; Zou X; Xu L
    Exp Biol Med (Maywood); 2016 Feb; 241(3):265-72. PubMed ID: 26376826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hispidulin potentiates the antitumor effect of sunitinib against human renal cell carcinoma in laboratory models.
    Gao H; Jiang Q; Han Y; Peng J; Wang C
    Cell Biochem Biophys; 2015 Mar; 71(2):757-64. PubMed ID: 25260394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
    Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
    Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth Inhibitory and Pro-Apoptotic Effects of Hirsuteine in Chronic Myeloid Leukemia Cells through Targeting Sphingosine Kinase 1.
    Gao S; Guo T; Luo S; Zhang Y; Ren Z; Lang X; Hu G; Zuo D; Jia W; Kong D; Yu H; Qiu Y
    Biomol Ther (Seoul); 2022 Nov; 30(6):553-561. PubMed ID: 35702821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.
    Pchejetski D; Golzio M; Bonhoure E; Calvet C; Doumerc N; Garcia V; Mazerolles C; Rischmann P; Teissié J; Malavaud B; Cuvillier O
    Cancer Res; 2005 Dec; 65(24):11667-75. PubMed ID: 16357178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine kinase 1 overexpression contributes to sunitinib resistance in clear cell renal cell carcinoma.
    Xu Y; Dong B; Wang J; Zhang J; Xue W; Huang Y
    Oncoimmunology; 2018; 7(12):e1502130. PubMed ID: 30524898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
    Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
    Maceyka M; Payne SG; Milstien S; Spiegel S
    Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physcion 8-O-β-glucopyranoside exhibits anti-leukemic activity through targeting sphingolipid rheostat.
    Han J; Zhao P; Shao W; Wang Z; Wang F; Sheng L
    Pharmacol Rep; 2018 Oct; 70(5):853-862. PubMed ID: 30092415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.